Biochemistry, Genetics and Molecular Biology
Transcription Factor Nrf2
84%
Genomics
71%
Solution Structure
55%
Metabolite
50%
Genetics
48%
Cancer Cell
36%
Cohort Study
35%
Gene Expression
33%
Genome-Wide Association Study
32%
Genotyping
31%
Transcription Factor Maf
31%
Metabolomics
31%
Programmed Cell Death
30%
Oxidative Stress
29%
C-Terminus
26%
Alanine
25%
Amino Acids
24%
Wild Type
24%
Prospective Cohort Study
24%
Metabolic Pathway
23%
Gene Expression Profiling
23%
Aspartic Acid
22%
N-Terminus
21%
Blood Plasma
21%
P53
21%
Transcription
21%
Metabolome
20%
Whole Genome Sequencing
20%
Cysteine
19%
Transcription Factors
19%
Genetic Divergence
18%
Cisplatin
18%
Tamsulosin
18%
Escherichia coli
17%
Synapsin I
17%
Enzyme
17%
KEAP1
17%
Knockout Mouse
17%
Enhancer Region
17%
Single-Nucleotide Polymorphism
16%
Nuclear Magnetic Resonance Spectroscopy
16%
Cell Proliferation
16%
Anticancer
15%
Messenger RNA
15%
Antiporter
15%
Allele
14%
Single-Stranded DNA
14%
Binding Site
14%
Next Generation Sequencing
14%
Tetragenococcus halophilus
13%
Flavin Containing Monooxygenase 3
13%
Heme Oxygenase
13%
Binding Protein
13%
BRCA1
13%
Transcription Initiation
12%
Thermus thermophilus
12%
Antioxidant Responsive Element
11%
Proteome
11%
Protein Interaction
11%
Unfolded Protein Response
11%
Protein Kinase B
11%
Protein Expression
11%
Homeostasis
11%
Enzyme Activity
11%
Transcription Factor Nrf1
11%
Exome
11%
Exon
11%
DNA Binding
11%
Phosphotransferase
10%
Kinase
10%
Promoter Region
10%
Exome Sequencing
10%
Fluorouracil
10%
Western Blot
9%
Protein P53
9%
Enzyme Active Site
9%
Proline
9%
DNA-binding Protein
9%
Molecular Network
9%
Gene Mutation
9%
Mouse Mutant
9%
X Chromosome
9%
Ubiquitin
9%
RNA Sequence
9%
Proteasome
8%
Isotope Labeling
8%
Germ Cell
8%
Cell Growth
8%
Solution and Solubility
8%
Blood Pressure
8%
Metabolome Analysis
8%
Hydroxylation
8%
Magnetism
8%
Contact Inhibition
8%
Subcellular Localization
8%
IC50
8%
Dihydropyrimidinase
8%
Hypoxia Inducible Factor 1
8%
Skeletal Muscle
8%
Chemosensitivity
8%
Medicine and Dentistry
Cervical Cancer
100%
Ovarian Cancer
62%
Neoplasm
57%
Uterine Cancer
48%
Cohort Analysis
43%
Radical Hysterectomy
43%
Diseases
33%
Overall Survival
31%
Paclitaxel
30%
Carboplatin
28%
Recurrent Disease
28%
Gynecological Oncology
28%
Adenocarcinoma
27%
Squamous Cell Carcinoma
26%
Female Genital Tract Cancer
25%
Cancer
24%
Krukenberg Tumor
24%
Progression Free Survival
24%
Cisplatin
19%
Adjuvant Therapy
19%
Survival Rate
19%
Uterine Cervix
19%
Medicine
19%
Malignant Neoplasm
18%
Biological Marker
18%
Gynecology
18%
Obstetrics
17%
Pelvis
17%
First-Line Chemotherapy
17%
Hazard Ratio
16%
Prognostic Factor
16%
Retroperitoneal Lymph Node Dissection
16%
Neoadjuvant Chemotherapy
16%
Metabolomics
16%
Cell Signaling Pathway
16%
Radiation Therapy
15%
Clear Cell Carcinoma
14%
Mucinous Carcinoma
14%
Tamsulosin
13%
Endometrium Carcinoma
13%
Lymph Node Metastasis
13%
Adjuvant Chemotherapy
13%
Blood Pressure
13%
Programmed Cell Death
12%
Gene Expression Profiling
12%
Transcription Factor Nrf2
12%
Unfolded Protein Response
12%
Prospective Cohort Study
12%
Cancer Cell
11%
Clinical Stage
11%
Cell Line
11%
Retrospective Study
11%
Dose Densification
11%
Sentinel Lymph Node Biopsy
11%
Personalized Medicine
10%
Chemoradiotherapy
10%
Fallopian Tube
10%
Uterine Fibroid
10%
Organoid
10%
Human Phenotype Ontology
10%
BRCA1
10%
Homologous Recombination
10%
Cancer Staging
10%
Maintenance Therapy
10%
Odds Ratio
10%
Cell Proliferation
10%
Carcinoma
10%
Quality of Life
9%
Lymph Node
9%
Cytoreductive Surgery
9%
Computer Assisted Tomography
9%
Adverse Event
9%
Protein P53
9%
Retrospective Cohort Study
9%
Magnetic Resonance Imaging
9%
Wart Virus
8%
Disease Free Survival
8%
Gene Expression
8%
Disease
8%
Protein Kinase B
8%
Postpartum Depression
8%
Depressive Disorder
8%
Alzheimer's Disease
8%
Metabolite
8%
Multivariate Analysis
7%
Intermediate Risk Population
7%
Docetaxel
7%
Combination Therapy
7%
Adjuvant Radiotherapy
7%
T Cell
7%
Phosphoinositide 3-Kinase
7%
Symptomatic Treatment
7%
Biopsy Technique
7%
Ovary Metastasis
6%
Diagnosis
6%
Radical Surgery
6%
Carcinoma Cell
6%
Genetic Risk
6%
Genome Sequencing
6%
Leiomyosarcoma
6%
Pharmacology, Toxicology and Pharmaceutical Science
Ovary Cancer
57%
Chemotherapy
55%
Neoplasm
41%
Uterine Cervix Cancer
39%
Paclitaxel
37%
Biological Marker
35%
Malignant Neoplasm
33%
Diseases
31%
Carboplatin
29%
Cisplatin
29%
Transcription Factor Nrf2
28%
Progression Free Survival
20%
Protein P53
20%
Ovary Carcinoma
18%
Amino Acid
16%
Endometrium Cancer
16%
Cohort Study
16%
First-Line Chemotherapy
16%
Overall Survival
15%
Recurrent Disease
14%
Hypoxia
12%
Squamous Cell Carcinoma
12%
Adenocarcinoma
10%
Curcumin
10%
Heme Oxygenase 1
10%
Erythropoietin
9%
Adverse Event
9%
Protein Kinase B
9%
Anticancer Drug
9%
Escherichia coli
9%
Endometrium Carcinoma
9%
Docetaxel
9%
Female Genital Tract Cancer
9%
Taxane
8%
Clear Cell Carcinoma
8%
Survival Rate
8%
Bevacizumab
8%
Prevalence
8%
Nedaplatin
8%
Telomerase
8%
Leiomyosarcoma
8%
Dihydropyrimidinase
8%
Depressive Disorder
8%
Cytoprotective Agent
7%
Pazopanib
7%
Cytotoxicity
7%
Phosphatidylinositol 3 Kinase
7%
Knockout Mouse
6%
Transcription Factors
6%
Fluorouracil
6%
Stable Isotope
6%
Messenger RNA
6%
Chemoradiation Therapy
6%
Doxorubicin
6%
Placebo
6%
Anti-Inflammatory Drug
6%
Neutropenia
6%
Lethality
6%
Uterus Myoma
6%
Heme
6%
Carcinoma
5%
Mouse Model
5%
CYP3A4
5%
Cytokine
5%
Tumor Growth
5%
Diabetic Nephropathy
5%
Inflammation
5%
Irinotecan
5%
Human Papillomavirus
5%
Visual Pigment
5%
Cytochrome P450
5%
Iron
5%
Mitogen Activated Protein Kinase
5%
Roxadustat
5%
Colloid Carcinoma
5%
Hypoxia Inducible Factor 1
5%
Postnatal Depression
5%
Fibrinogen
5%
Mammalian Target of Rapamycin
5%
Halofuginone
5%
Biguanide Derivative
5%
Rare Disease
5%
Nitric Oxide
5%
Isotopes of Potassium
5%
Abdominal Cancer
5%
Peritoneum Tumor
5%
Tamsulosin
5%
Prospective Cohort Study
5%
Low Birth Weight
5%
Geldanamycin
5%
Alzheimer's Disease
5%
Solid Malignant Neoplasm
5%
12-O-Tetradecanoylphorbol-13-Acetate
5%